WE1.R2.2
DEVELOPMENT OF PHARMACEUTICALLY-RELEVANT PHOSPHOLIGANDS FROM LAB TO PLANT VIA MULTI-STAGE FLOW CHEMISTRY
Eric Sacia, Anna Bay, Shashank Shekhar, Kaid Harper, Justin Simanis, Simona Slater, Onkar Manjrekar, Christopher Vitale, AbbVie
Session:
WE1.R2: Biopharmaceutical Reaction Engineering I
Track:
Biopharmaceutical Reaction Engineering – All Modalities
Location:
Galleria III
Presentation Time:
Wed, 19 Feb, 09:50 - 10:10 CT (UTC -5)
Session Co-Chairs:
Bryan Patel, ExxonMobil and Jane Shi, Dow
Presentation
Discussion
Resources
No resources available.
Session WE1.R2
WE1.R2.1: Development of continuous hydrogenation for pharmaceutical intermediate from Laboratory to Pilot plant
Onkar Manjrekar, Greg Storer, Brian Kotecki, Jie Chen, Moiz Diwan, AbbVie
WE1.R2.2: DEVELOPMENT OF PHARMACEUTICALLY-RELEVANT PHOSPHOLIGANDS FROM LAB TO PLANT VIA MULTI-STAGE FLOW CHEMISTRY
Eric Sacia, Anna Bay, Shashank Shekhar, Kaid Harper, Justin Simanis, Simona Slater, Onkar Manjrekar, Christopher Vitale, AbbVie
WE1.R2.3: DEVELOPMENT AND DEMONSTRATION OF AN ULTRA-HIGH TEMPERATURE CONTINUOUS RACEMIZATION PROCESS FOR RECYCLE OF UNDESIRED ATROPISOMER WASTE STREAM
Kiersten Campbell, Eric Fang, David Ford, Kevin Nagy, Jillian Sheeran, Snapdragon Chemistry, Inc., A Cambrex Company
Contacts